News

A novel drug-delivery technology that uses a harmless virus to deliver an antibody gene into human cells can lead to sustained antibody production; this strategy could be applied to other infectious diseases.

Using a skin cream infused with microscopic STAR particles and a therapeutic drug, a team from the Georgia Institute of Technology has created a therapy that could facilitate better treatment of skin diseases.

Scientists have identified a mechanism by which the bacterium Pseudomonas aeruginosa can evade antibiotics by surrounding its cells with a self-made protective casing.

Turning genes on and off as needed allows an organism to adapt to changes in the environment—provided the organism has a specific regulatory design in place. Scientists have shown that under rare or rapidly changing conditions, the fitness of a population of bacteria can increase simply by producing a higher number of copies of one and the same gene. The results are highly relevant in resistance to antibiotics treatment.

On 6 March, the International Space Station resupply mission Space X CRS-20 took off from Cape Canaveral. On board: 250 test tubes from the University of Zurich containing adult human stem cells. These stem cells will develop into bone, cartilage and other organs during the month-long stay in space.

Scientists from a Medical University of Vienna start-up may have found a way to stop rhinovirus and therefore might have discovered a new therapy for treating colds in the future.

A new method of bioprinting uses aspiration of tiny biologics such as spheroids, cells and tissue strands, to precisely place them in 3D patterns either on scaffolding or without to create artificial tissues with natural properties.

Scientists have introduced a new route for the total synthesis of tetrodotoxin, a puffer fish toxin that could be used as a replacement for opioids for relieving cancer related pain.

Scientists have discovered that bacteria that usually live in the gut can penetrate and accumulate in tumors and improve the effectiveness of immunotherapy in mice.

The failure of the body to easily absorb curcumin has been a thorn in the side of medical researchers seeking scientific proof that curcumin can successfully treat a number of health conditions. Now, researchers have shown that curcumin can be delivered effectively into human cells via tiny nanoparticles.